BSP实施种植体周围疾病预防与治疗:EFP S3级临床实践指南
该指南将欧洲牙周病学联合会(EFP)的种植体周围疾病预防与治疗S3级临床实践指南改编用于英国医疗环境,采用GRADE ADOLOPMENT框架,基于13项系统综述的证据,由111名代表组成的指南小组形成55条临床推荐,旨在促进一致、跨学科、循证的预防与治疗。
要点
- 基于EFP S3级指南,采用ADOLOPMENT框架改编适用于英国。
- 涵盖55条种植体周围疾病预防与治疗的临床推荐。
- 证据来自13项系统综述,经共识会议形成推荐。
核心结论
- 采用ADOLOPMENT协议制定了英国版EFP S3级种植体周围疾病预防与治疗临床实践指南。
- 该指南提供基于证据和共识的临床推荐,直接适用于英国医疗社区包括公众。
研究设计与样本
- 基于EFP S3级指南,使用GRADE ADOLOPMENT框架进行改编。
- 证据来自13项系统综述的正式评估。
- 指南小组由来自26个利益相关组织的111名代表组成四个工作组。
主要发现
- 形成了55条基于牙周和种植体周围疾病分类的临床推荐。
- 所有临床推荐均经过正式评估其英国适用性并进行调整。
关键数值与推荐
- 涵盖55条种植体周围疾病预防与治疗的临床推荐。
- 推荐基于13项系统综述的证据和共识过程。
临床怎么用
- 为英国医疗系统提供一致、跨学科、循证的种植体周围疾病预防与治疗方法。
- 促进公众参与和临床适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: to adapt the supranational European Federation of Periodontology (EFP) Prevention and Treatment of Peri-implant Diseases - The EFP S3 Level Clinical Practice Guideline for UK healthcare environment, taking into account a broad range of views from stakeholders and patients. SOURCES: This UK version, based on the supranational EFP guideline [1] published in the Journal of Clinical Periodontology, was developed using S3-level methodology, combining assessment of formal evidence from 13 systematic reviews with a moderated consensus process of a representative group of stakeholders, and accounts for health equality, environmental factors and clinical effectiveness. It encompasses 55 clinical recommendations for the Prevention and Treatment of Peri-implant Diseases, based on the classification for periodontal and peri‑implant diseases and conditions [2]. METHODOLOGY: The UK version was developed from the source guideline using a formal process called the GRADE ADOLOPMENT framework. This framework allows for adoption (unmodified acceptance), adaptation (acceptance with modifications) and the de novo development of clinical recommendations. Using this framework, following the S3-process, the underlying evidence was updated and a representative guideline group of 111 delegates from 26 stakeholder organisations was assembled into four working groups. Following the formal S3-process, all clinical recommendations were formally assessed for their applicability to the UK and adoloped accordingly. RESULTS AND CONCLUSION: Using the ADOLOPMENT protocol, a UK version of the EFP S3-level clinical practice guideline for the Prevention and Treatment of Peri-implant Diseases was developed. This guideline delivers evidence- and consensus-based clinical recommendations of direct relevance to the UK healthcare community including the public. CLINICAL SIGNIFICANCE: The S3-level-guidelines combine evaluation of formal evidence, grading of recommendations and synthesis with clinical expertise of a broad range of stakeholders. The international S3-level-guideline was implemented for direct clinical applicability in the UK healthcare system, facilitating a consistent, interdisciplinary, evidence-based approach with public involvement for the prevention and treatment of peri‑implant diseases.
引用
- West N, Chapple I, Culshaw S, et al. BSP Implementation of prevention and treatment of peri-implant diseases - The EFP S3 level clinical practice guideline. J Dent. 2024. PMID: 38697506. doi:10.1016/j.jdent.2024.104980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。